Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Rentokil
RTO
|
+$514M |
| 2 |
APLS
Apellis Pharmaceuticals
APLS
|
+$210M |
| 3 |
TFI International
TFII
|
+$145M |
| 4 |
Ambev
ABEV
|
+$142M |
| 5 |
Vanguard S&P 500 ETF
VOO
|
+$133M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$8.38B |
| 2 |
Apple
AAPL
|
+$5.7B |
| 3 |
Amazon
AMZN
|
+$3.72B |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$3.64B |
| 5 |
Mastercard
MA
|
+$3.47B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.11% |
| 2 | Healthcare | 21.42% |
| 3 | Financials | 11.42% |
| 4 | Industrials | 10.73% |
| 5 | Consumer Discretionary | 10.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
901
Pembina Pipeline
PBA
$28.5B
| $4.17M | ﹤0.01% |
122,815
-19,415
| -14% | -$651K |
|
902
PACCAR
PCAR
$70.1B
| $4.15M | ﹤0.01% |
62,943
-56,853
| -47% | -$3.71M |
|
903
Equifax
EFX
$20.4B
| $4.12M | ﹤0.01% |
21,178
-9,922
| -32% | -$1.81M |
|
904
Onto Innovation
ONTO
$12.9B
| $4.12M | ﹤0.01% |
60,435
-61,451
| -50% | -$4.41M |
|
|
HPP
905
Hudson Pacific Properties
HPP
$754M
| $4.09M | ﹤0.01% |
60,117
-76,135
| -56% | -$5.65M |
|
|
LCA
906
DELISTED
Landcadia Holdings IV, Inc. Class A Common Stock
LCA
| $4.09M | ﹤0.01% |
409,157
-356,473
| -47% | -$3.55M |
|
907
Vanguard Long-Term Corporate Bond ETF
VCLT
$8.79B
| $4.08M | ﹤0.01% |
53,870
+7,814
| +17% | +$587K |
|
908
Albemarle
ALB
$13.8B
| $4.07M | ﹤0.01% |
18,773
-10,565
| -36% | -$2.82M |
|
909
Eversource Energy
ES
$27.3B
| $4M | ﹤0.01% |
47,745
-47,751
| -50% | -$3.79M |
|
|
AGGR
910
DELISTED
Agile Growth Corp
AGGR
| $3.98M | ﹤0.01% |
394,570
-394,568
| -50% | -$3.95M |
|
|
UMPQ
911
DELISTED
Umpqua Holdings Corp
UMPQ
| $3.95M | ﹤0.01% |
221,605
-251,921
| -53% | -$4.74M |
|
912
Constellation Energy
CEG
$93.5B
| $3.94M | ﹤0.01% |
45,754
-39,962
| -47% | -$3.6M |
|
|
CMA
913
DELISTED
Comerica
CMA
| $3.93M | ﹤0.01% |
58,849
-11,023
| -16% | -$764K |
|
914
D.R. Horton
DHI
$40.3B
| $3.92M | ﹤0.01% |
44,027
-47,633
| -52% | -$3.82M |
|
|
DRAY
915
DELISTED
Macondray Capital Acquisition Corp. I Class A Ordinary Shares
DRAY
| $3.88M | ﹤0.01% |
380,183
-380,183
| -50% | -$3.84M |
|
916
Toro Company
TTC
$8.75B
| $3.84M | ﹤0.01% |
33,906
-32,254
| -49% | -$3.42M |
|
917
Graco
GGG
$12.9B
| $3.82M | ﹤0.01% |
56,871
-54,643
| -49% | -$3.64M |
|
918
Larimar Therapeutics
LRMR
$393M
| $3.82M | ﹤0.01% |
927,269
-672,731
| -42% | -$2.3M |
|
|
HCNE
919
DELISTED
Jaws Hurricane Acquisition Corp. Class A Common Stock
HCNE
| $3.79M | ﹤0.01% |
+380,201
| New | +$3.75M |
|
920
Lattice Semiconductor
LSCC
$17.7B
| $3.79M | ﹤0.01% |
58,343
+7,397
| +15% | +$446K |
|
|
ALCE
921
DELISTED
Alternus Clean Energy Inc
ALCE
| $3.78M | ﹤0.01% |
14,941
-14,928
| -50% | -$3.72M |
|
922
Progyny
PGNY
$2.45B
| $3.78M | ﹤0.01% |
121,397
-137,625
| -53% | -$4.98M |
|
923
Enliven Therapeutics
ELVN
$3.84B
| $3.77M | ﹤0.01% |
+232,177
| New | +$3.71M |
|
924
Masco
MAS
$14.1B
| $3.76M | ﹤0.01% |
80,544
-286,084
| -78% | -$13.8M |
|
925
Essex Property Trust
ESS
$18.3B
| $3.75M | ﹤0.01% |
17,685
-633,853
| -97% | -$139M |
|
Similar funds
Janus Henderson Group's Q4 2022 Portfolio in Review
As of Q4 2022, Janus Henderson Group held 2,666 positions worth $140B, down 48% from $267B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Janus Henderson Group withdrew a net $148B in Q4 2022, closing 210 positions and reducing 1,907 holdings. Its most notable exit was Terminix Global Holdings, Inc., an estimated $901M position sold in full.
By sector, the portfolio is most concentrated in Technology at 28% of assets, down from 30% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Janus Henderson Group opened a new position in Rentokil worth $510M.
- Janus Henderson Group's largest Q4 2022 buy was Rentokil: 16,564,405 shares worth $510M.
- Janus Henderson Group added most to Apellis Pharmaceuticals in Q4 2022, an estimated $210M increase.
- Janus Henderson Group's biggest Q4 2022 reduction was Microsoft, cutting an estimated $8.38B.
- Janus Henderson Group fully exited Terminix Global Holdings, Inc. in Q4 2022, selling an estimated $901M.
- Janus Henderson Group's ten largest holdings make up 22% of its $140B portfolio in Q4 2022.
- Janus Henderson Group opened 131 new positions and closed 210 in Q4 2022.
- Janus Henderson Group's portfolio value fell 48% quarter-over-quarter to $140B.
Based on Janus Henderson Group's 13F filing for Q4 2022, filed 14 Feb 2023.